phentermine has been researched along with Diabetic Angiopathies in 3 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse-controlled release (DCR) in patients with obesity." | 9.14 | Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. ( Kang, JG; Kang, JH; Park, CY; Park, SW; Park, YW, 2010) |
| "To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse-controlled release (DCR) in patients with obesity." | 5.14 | Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. ( Kang, JG; Kang, JH; Park, CY; Park, SW; Park, YW, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalarchian, M | 1 |
| Turk, M | 1 |
| Elliott, J | 1 |
| Gourash, W | 1 |
| Kang, JG | 1 |
| Park, CY | 1 |
| Kang, JH | 1 |
| Park, YW | 1 |
| Park, SW | 1 |
| Hendricks, EJ | 1 |
| Rothman, RB | 1 |
1 review available for phentermine and Diabetic Angiopathies
| Article | Year |
|---|---|
Lifestyle management for enhancing outcomes after bariatric surgery.
Topics: Appetite Depressants; Bariatric Surgery; Behavior Therapy; Comorbidity; Diabetes Mellitus, Type 2; D | 2014 |
1 trial available for phentermine and Diabetic Angiopathies
| Article | Year |
|---|---|
Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity.
Topics: Adult; Appetite Depressants; Delayed-Action Preparations; Diabetic Angiopathies; Double-Blind Method | 2010 |
1 other study available for phentermine and Diabetic Angiopathies
| Article | Year |
|---|---|
Phentermine therapy for obesity does not elevate blood pressure.
Topics: Appetite Depressants; Delayed-Action Preparations; Diabetic Angiopathies; Dyslipidemias; Female; Hum | 2011 |